Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual

Surgical Clinics of North America - Tập 83 Số 4 - Trang 803-819 - 2003
S. Eva Singletary1, Craig Allred2, Pandora Ashley3, Lawrence W. Bassett4, Donald A. Berry5, Kirby I. Bland, Patrick I. Borgen6, Gary M. Clark7, Stephen B. Edge8, Daniel F. Hayes9, Lorie L. Hughes10, R. V. P. Hutter11, Monica Morrow12, D. Timothy Bishop13, Abram Recht14, Richard L. Theriault15, Ann D. Thor16, Donald L. Weaver17, H. Samuel Wieand18, Frederick L. Greene19
1Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 106, Houston, TX 77030-4009, USA
2Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 USA
3Certified Tumor Registry, Scott and White Memorial Hospital, 2401 South 31st Street, Temple, TX 76508, USA
4Department of Radiological Sciences, Breast Imaging Section,University of California–Los Angeles, 200 East UCLA Medical Plaza,Room 165-47, Los Angeles, CA 90095, USA
5Department of Biostatistics, University of Texas M.D. AndersonCancer Center, 1515 Holcombe Boulevard, Box 447, Houston, TX 77030-4009, USA
6Breast Service in Department of Surgery, Memorial Sloan-Kettering Cancer Center,1275 York Avenue, Room 1026, MRI, New York, NY 10021, USA
7Biostatistics and Data Management, OSI Farmaceuticals Inc.,2860 Wilderness Place, Boulder, CO 80301, USA
8Breast and Soft Tissue Surgery, Division of Surgical Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA
9Breast Oncology Program, University of Michigan, 6312 CCGC, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0942, USA
102871 Mabry Road, Atlanta, GA 30319, USA
11Department of Pathology, Saint Barnabas Medical Center, 30 Surrey Lane, Livingston, NJ 07039, USA
12Department of Surgery, Northwestern Memorial Hospital, 251 East Huron St., Galter-13-174, Chicago IL 60611, USA
13Department of Anatomic Pathology, Vanderbilt University Medical Center, 21st Avenue South, Room C-3308, MCN, Nashville, TN 37232-2561, USA
14Department of Radiation Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Building B25, Boston, MA 02215-5400, USA
15University of Texas M.D. Anderson Cancer Center, 7505 South Main Street, Suite 450, Houston, TX 77030, USA
16Department of Pathology—BMSB 451, University of Oklahoma Health Science Center, 940 Stanton L. Young Boulevard, Oklahoma City, OK 73104, USA
17Department of Pathology (Smith 247), Fletcher Allen Health Care, 111 Colchester Avenue, Burlington, VT 05401, USA
18Biostatistics Graduate School of Public Health, The University of Pittsburgh Cancer Institute Biostatistics Facility, National Surgical Adjuvant, Breast and Bowel Project, 201 North Craig Street, Suite 350, Pittsburgh, PA 15213, USA
19Department of General Surgery, Carolinas Medical Center, P.O. Box 32861, Charlotte, NC 28232, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Fleming, 1997

Cady, 1996, The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening, Arch Surg, 131, 301, 10.1001/archsurg.1996.01430150079015

Haagensen, 1986

Maunsell, 1993, Arm problems and psychological distress after surgery for breast cancer, Can J Surg, 36, 315

Singletary, 2001, Systemic treatment following sentinel lymph node biopsy in breast cancer: who, what, and why?, J Am Coll Surg, 192, 220, 10.1016/S1072-7515(00)00775-4

Yarbro, 1999, American Joint Committee on Cancer Prognostic Factors Consensus Conference, Cancer, 86, 2436, 10.1002/(SICI)1097-0142(19991201)86:11<2436::AID-CNCR35>3.0.CO;2-#

Fitzgibbons, 2000, Prognostic factors in breast cancer: College of American Pathologists consensus Statement 1999, Arch Pathol Lab Med, 124, 966, 10.5858/2000-124-0966-PFIBC

Bast, 2001, 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology, J Clin Oncol, 19, 1865, 10.1200/JCO.2001.19.6.1865

Greene, 2002

Huvos, 1971, Significance of axillary macrometastases and micrometastases in mammary cancer, Ann Surg, 173, 44, 10.1097/00000658-197101000-00006

Chen, 1991, Occult metastases in the axillary lymph nodes of patients with breast cancer node-negative by clinical and histologic examination and conventional histology, Dis Markers, 9, 238

Clare, 1997, Prognostic significance of occult lymph node metastases in node-negative breast cancer, Ann Surg Oncol, 4, 447, 10.1007/BF02303667

De Mascarel, 1992, Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: re-evaluation with longer follow-up, Br J Cancer, 66, 523, 10.1038/bjc.1992.306

Hainsworth, 1993, Detection and significance of occult metastases in node-negative breast cancer, Br J Surg, 80, 459, 10.1002/bjs.1800800417

Senmak, 1989, Prognostic significance of cytokeratin-positive breast cancer metastases, Mod Pathol, 2, 516

Branagan, 2002, Detection of micrometastases in lymph nodes from patients with breast cancer, Br J Surg, 89, 86, 10.1046/j.0007-1323.2001.01970.x

Ishida, 2002, Detection of micrometastasis in the sentinel lymph nodes in breast cancer, Surgery, 131, S211, 10.1067/msy.2002.119579

Mitas, 2001, Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel, Int J Cancer, 93, 162, 10.1002/ijc.1312

Abati, 1996, Looking forward in diagnostic pathology. The molecular superhighway, Cancer, 78, 1, 10.1002/(SICI)1097-0142(19960701)78:1<1::AID-CNCR1>3.0.CO;2-S

Stearns, 2002, Sentinel lymphadenectomy following neoadjuvant chemotherapy for breast cancer accurately represents the axilla except for inflammatory breast cancer, Ann Surg Oncol, 9, 235, 10.1007/BF02573060

Breslin, 2000, Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer, J Clin Oncol, 18, 3480, 10.1200/JCO.2000.18.20.3480

Mamounas E, Brown A, Smith R, et al. Sentinel node biopsy following neoadjuvant chemotherapy in breast cancer: results from NSABP B-27. Proceedings from the Society of Surgical Oncology 54th Annual Cancer Symposium [abstract], Washington D.C., 2001.

Jatoi, 1999, Significance of axillary lymph node metastasis in primary breast cancer, J Clin Oncol, 17, 1334, 10.1200/JCO.1999.17.8.2334

Carter, 1989, Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases, Cancer, 63, 181, 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H

Crump, 1996, Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes, J Clin Oncol, 14, 66, 10.1200/JCO.1996.14.1.66

Diab, 1998, Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy, J Clin Oncol, 16, 1655, 10.1200/JCO.1998.16.5.1655

Fountzilas, 1998, Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >10 positive axillary lymph nodes. A feasibility study, Oncology, 55, 508, 10.1159/000011903

Nemoto, 1980, Management and survival of female breast cancer: results of a national survey by the American College of Surgeons, Cancer, 45, 2917, 10.1002/1097-0142(19800615)45:12<2917::AID-CNCR2820451203>3.0.CO;2-M

Newman, 2001, Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer, Am J Surg, 181, 313, 10.1016/S0002-9610(01)00588-8

Veronesi, 1999, The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomized trial, Eur J Cancer, 35, 1320, 10.1016/S0959-8049(99)00133-1

Klauber-DeMore, 2001, Comprehensive review of the management of internal mammary lymph node metastases in breast cancer, J Am Coll Surg, 193, 547, 10.1016/S1072-7515(01)01040-7

Halsted, 1907, The results of radical operations for the cure of cancer of the breast, Ann Surg, 46, 1, 10.1097/00000658-190707000-00001

Debois, 1997, The significance of a supraclavicular node metastasis in patients with breast cancer: a literature review, Strahlenther Onkol, 173, 1, 10.1007/BF03039187

Brito, 2001, Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center Experience, J Clin Oncol, 19, 628, 10.1200/JCO.2001.19.3.628

von Hansemann, 1890, Über assymetrische zelltheilung in epithelkrebsen und deren biologische bedeutung, Virchows Arch A Pathol Anat Histol, 119, 299, 10.1007/BF01882039

Greenough, 1925, Varying degrees of malignancy in cancer of the breast, J Cancer Res, 9, 452

Bloom, 1957, Histological grading and prognosis in breast cancer, Br J Cancer, 11, 359, 10.1038/bjc.1957.43

Elston, 1991, Pathological prognostic factors in breast cancer, Histopathology, 19, 403, 10.1111/j.1365-2559.1991.tb00229.x

D'Eredita, 2001, Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution, Eur J Cancer, 37, 591, 10.1016/S0959-8049(00)00435-4

Genestie, 1998, Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histologic grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems, Anticancer Res, 18, 571

Henson, 1991, Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer, Cancer, 68, 2142, 10.1002/1097-0142(19911115)68:10<2142::AID-CNCR2820681010>3.0.CO;2-D

Kollias, 1999, The prognosis of small primary breast cancers, Eur J Cancer, 35, 908, 10.1016/S0959-8049(99)00056-8

Leitner, 1995, Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,bN0M0), Cancer, 76, 2266, 10.1002/1097-0142(19951201)76:11<2266::AID-CNCR2820761114>3.0.CO;2-T

Lundin, 2001, Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: results from a nationwide study, J Clin Oncol, 19, 28, 10.1200/JCO.2001.19.1.28

Page, 2001, Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry, Am J Clin Oncol, 24, 10, 10.1097/00000421-200102000-00002

Reed, 2000, The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast cancer, Cancer, 88, 804, 10.1002/(SICI)1097-0142(20000215)88:4<804::AID-CNCR11>3.0.CO;2-Y

Rosen, 1989, Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years, J Clin Oncol, 7, 1239, 10.1200/JCO.1989.7.9.1239

Rosner, 1991, Should all patients with node-negative breast cancer receive adjuvant therapy?, Cancer, 68, 1482, 10.1002/1097-0142(19911001)68:7<1482::AID-CNCR2820680704>3.0.CO;2-J

Frkovic-Grazio, 2002, Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma, J Clin Pathol, 55, 88, 10.1136/jcp.55.2.88

Mirza, 2002, Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years, Ann Surg, 235, 10, 10.1097/00000658-200201000-00003

Thông tin
Thông tin xuất bản

Surgical Clinics of North America

Tập 83 Số 4

803-819

Thông tin tác giả